🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

12+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 12 recruiting trials for “Thymic carcinoma”

Phase 2RecruitingNCT07132918 ↗

HEARTS Trial for Thoracic Cancers

👨‍⚕️ Carri Glide-Hurst, PhD, DABR, FAAPM, University of Wisconsin, Madison📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06838910 ↗

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Mar 2025View details ↗
NARecruitingNCT06692062 ↗

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

🏥 Rongrong Zhou📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06248515 ↗

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

👨‍⚕️ Chul Kim, MD, Chul.Kim@gunet.georgetown.edu📍 4 sites📅 Started Apr 2024View details ↗
Phase 3RecruitingNCT06402708 ↗

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

🏥 Fudan University📍 1 site📅 Started Apr 2024View details ↗
Phase 3RecruitingNCT02633514 ↗

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

👨‍⚕️ Kailiang Wu, MD. PhD, Fudan University📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05832827 ↗

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

👨‍⚕️ Yusuke Okuma, MD, National Cancer Center, Japan📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06301945 ↗

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

🏥 Erasmus Medical Center📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT05104736 ↗

PT-112 in Subjects With Thymoma and Thymic Carcinoma

👨‍⚕️ Arun Rajan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2022View details ↗
Phase 1RecruitingNCT03295227 ↗

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

👨‍⚕️ Anne S Tsao, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2017View details ↗
RecruitingNCT05667948 ↗

Molecular Analysis and Treatment Options of Thymic Malignancies

🏥 Shanghai Chest Hospital📍 1 site📅 Started Jan 2016View details ↗
Enrolling by InvitationNCT01385722 ↗

Molecular Analysis of Thoracic Malignancies

👨‍⚕️ Joel Neal, Stanford University📍 1 site📅 Started Aug 2011View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →